Please try another search
CoLucid Pharmaceuticals, Inc. develops lasmiditan, an oral medication for the treatment of migraine. It serves patients and health care professionals. The company was founded in 2005 and is based in Cambridge, Massachusetts. CoLucid Pharmaceuticals, Inc. operates as a subsidiary of Eli Lilly and Company.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review